DelMar Pharmaceuticals to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 10-12, 2017

32

DelMar Pharmaceuticals LogoVANCOUVER, British Columbia and MENLO PARK, Calif., Sept. 6, 2017 /PRNewswire/ — DelMar Pharmaceuticals (Nasdaq: DMPI) (“DelMar” and “the Company”), a biopharmaceutical company focused on the development of new cancer therapies, today announced that Jeffrey Bacha, president & CEO of…


http://www.prnewswire.com/news-releases/delmar-pharmaceuticals-to-present-at-the-19th-annual-rodman–renshaw-global-investment-conference-on-september-10-12-2017-300514953.html